Unicycive Therapeutics, Inc.

UNCYNASDAQHealthcareBiotechnology

$3.59- (-)1Y −27.18%

As of Oct 15, 2026 close

Market cap: $96.63M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $3.59$8.74
Volume (live): -
Avg. volume (3M): 934.43K

Unicycive Therapeutics, Inc. (UNCY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Unicycive Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy

Based on 6 unique analysts

(7 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$25.50

+610.31% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest UNCY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 29, 2026	Swayampakula Ramakanth	HC Wainwright	Maintains	Buy	$15.00 → $13.00 −2.00 (−13.3%)
Aug 20, 2026	Bruce Jackson	StoneX	Maintains	Buy	$13.00 → $15.00 +2.00 (+15.4%)
Aug 18, 2026	Jason McCarthy	Maxim	Maintains	Buy	$30.00
Aug 13, 2026	Robert LeBoyer	Noble	Reiterates	Buy	$50.00
Aug 13, 2026	Vamil Divan	Guggenheim	Maintains	Buy	$37.00 → $25.00 −12.00 (−32.4%)
Aug 13, 2026	Mayank Mamtani	B Riley	Maintains	Buy	$22.00 → $20.00 −2.00 (−9.1%)
Aug 12, 2026	Vamil Divan	Guggenheim	Maintains	Buy	$37.00 → $25.00 −12.00 (−32.4%)

Swayampakula Ramakanth

HC Wainwright

BuyMaintains

$15.00 → $13.00

Sep 29

Bruce Jackson

StoneX

BuyMaintains

$13.00 → $15.00

Aug 20

Jason McCarthy

Maxim

BuyMaintains

$30.00

Aug 18

Robert LeBoyer

Noble

BuyReiterates

$50.00

Aug 13

Vamil Divan

Guggenheim

BuyMaintains

$37.00 → $25.00

Aug 13

Mayank Mamtani

B Riley

BuyMaintains

$22.00 → $20.00

Aug 13

Vamil Divan

Guggenheim

BuyMaintains

$37.00 → $25.00

Aug 12

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 29, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for UNCY?

The analyst consensus rating for UNCY is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for UNCY?

The average 12-month price target for UNCY is $25.50, representing an upside of 610.3% from the Oct 15, 2026 close of $3.59.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.